Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21064437 | 0.82 | PTGS1 (0.32) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL1805336 | 0.79 | PTGS1 (0.45) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL8553873 | 0.77 | CYP2D6 (0.34) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL11148783 | 0.77 | — | — | |
| SCHEMBL30026428 | 0.76 | PTGS1 (0.43) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL901982 | 0.72 | — | — | |
| SCHEMBL8513206 | 0.72 | APP (0.42) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL1979880 | 0.70 | — | — | |
| SCHEMBL11334251 | 0.70 | — | — | |
| SCHEMBL4883135 | 0.70 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-6014778-A | — | — | None | — | — | JP | disclosed |
| US-11307206-B2 | Functionalized metal-labeled beads for mass cytometry | DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DE) | 2022-04-19 | — | — | US | disclosed |
| EP-3570034-A2 | FUNCTIONALIZED METAL-LABELED BEADS FOR MASS CYTOMETRY | Deutsches Rheuma-Forschungszentrum Berlin (DE) | 2019-11-20 | — | — | EP | disclosed |
| US-20190331689-A1 | FUNCTIONALIZED METAL-LABELED BEADS FOR MASS CYTOMETRY | DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN (DE) | 2019-10-31 | — | — | US | disclosed |
| EP-2163542-B1 | Bi-functional compound positively charged at first pH and negatively charged at second pH, solid support comprising the bi-functional compound, and method of isolating nucleic acid using the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2014-05-14 | — | — | EP | disclosed |
| US-8535650-B2 | Drug delivery; bioavailability; mixture containing glycerides ,surfactant and stabilizer | SOLIGENIX, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8415277-B2 | Bi-functional compound positively charged at first pH and negatively charged at second pH, solid support comprising the bi-functional compound, and method of isolating nucleic acid using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-09 | — | — | US | disclosed |
| US-8263532-B2 | Microarray substrate, method of use, and products comprising the microarray substrate | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-09-11 | — | — | US | disclosed |
| EP-1674570-B1 | Method of isolating nucleic acid using material positively charged at first pH and containing amino group and carboxyl group | SAMSUNG ELECTRONICS CO LTD (KR) | 2010-12-01 | — | — | EP | disclosed |
| US-7816315-B2 | Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first pH and a solid material for nucleic acid isolation used for the method | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-10-19 | — | — | US | disclosed |
| WO-2000076476-A1 | ADJUVANT-CONTAINING POLYMERIZED LIPOSOMES FOR ORAL, MUCOSAL OR INTRANASAL VACCINATION | ENDOREX CORPORATION (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000067779-A2 | POLYMERIZED LIPOSOMES FOR THE DELIVERY OF MAMMALIAN GROWTH HORMONE | ENDOREX CORPORATION (US) | 2000-11-16 | — | — | WO | disclosed |
| EP-1049759-A1 | NOVEL POLYMERIZABLE FATTY ACIDS, PHOSPHOLIPIDS AND POLYMERIZED LIPOSOMES THEREFROM | Orasomal Technologies, Inc. (US) | 2000-11-08 | — | — | EP | disclosed |
| US-6060082-A | PHOSPHOLIPID BILAYER HAVING COVALENTLY BONDED PHOSPHOLIPIDS, AN AQUEOUS CORE AND A LECTIN WHEREIN THE LECTIN IS ULEX EUROPEANS AGGLUTININ I. | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-05-09 | — | — | US | disclosed |
| US-6004534-A | POLYMERIZED LIPOSOMES WHICH HAVE BEEN MODIFIED, PREFERABLY ON THEIR SURFACE, TO CONTAIN MOLECULE OR LIGAND WHICH TARGETS SPECIFIC SITE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1999033940-A1 | NOVEL POLYMERIZABLE FATTY ACIDS, PHOSPHOLIPIDS AND POLYMERIZED LIPOSOMES THEREFROM | ORASOMAL TECHNOLOGIES, INC. (US) | 1999-07-08 | — | — | WO | disclosed |
| CN-1169986-A | 2.9-diamino-and 2-amino-8-carbamoyl-4-hydroxy-aldanoic acid amide derivatives | CIBA GEIGY AG (CH) | 1998-01-14 | — | — | CN | disclosed |
| WO-1995003035-A1 | POLYMERIZED LIPOSOMES WITH ENHANCED STABILITY FOR ORAL DELIVERY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1995-02-02 | — | — | WO | disclosed |
| JP-H0614778-A | STABILIZATION OF 1-METHYLHYDANTOINASE, USE OF STABILIZED 1-METHYLHYDANTOINASE FOR MEASURING ANALYTE, CORRESPONDING DETERMINATION AND REAGENT SUITABLE FOR THE SAME | BOEHRINGER MANNHEIM GMBH | 1994-01-25 | — | — | JP | disclosed |
| US-4711852-A | STABILIZING ERYTHROCYTES WITH PROTEIN CROSSLINKING AGENT, BUFFERED SUSPENSION, OXYGEN AND CARBON MONOXIDE | AKZO N.V. (NL) | 1987-12-08 | — | — | US | disclosed |